Akoya Biosciences, Inc.

Termination of a Material Definitive Agreement. In connection with and substantially concurrently with the occurrence of the Merger, on July 8, 2025, Akoya repa

is incorporated herein by reference. As a result of the Merger, effective as of the Effective Time and pursuant to the Merger Agreement, (i) each of Myla Lai-Go

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. The information set forth in the Introductory Note and in I

Material Modification to the Rights of Security Holders. The information set forth in the Introductory Note, Item 2.01, Item 3.01 and Item 5.03 is incorporated

Changes in Control of Registrant. The information set forth in the Introductory Note and in Item 2.01, Item 3.03, Item 5.02 and Item 5.03 is incorporated herein

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. The informati

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The information set forth in the Introductory Note and in Item 2.01 is incorporated he

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 2.1* Amended and Restated Agreement and Plan of Merger, dated April 28, 2025, by and am